The people behind NasoClenz

Dr. Lebovic MA, MD, FACS has committed her career to improving the delivery of healthcare, with a special interest in the diagnosis and treatment of patients with breast cancer. Internationally recognized for her groundbreaking work as an Oncoplastic Surgeon, Dr. Lebovic is also highly regarded as a creative inventor and successful serial entrepreneur in the field of medical device development.

LINK TO FULL BIO

Joy brings two decades of operational experience spanning corporate America and founder-led startups. Time spent supporting senior executives at Disney gave her a foundation she then carried into building her own ventures. As General Manager of a wellness marketing startup and co-founder of a yoga and wellness studio in Los Angeles, she learned to build operational infrastructure from the ground up. Joy joins SVI with a passion for health & wellness, ensuring the leadership vision translates into seamless daily execution.

Edward Lamb is a veteran biotechnology and medical device executive with deep expertise in scaling homegrown life-science innovations into highly successful global commercial enterprises. Most recently serving as the Chief Executive Officer of Chitogel Limited, Ed spearheaded the company’s international growth strategy, turning a pioneering New Zealand-born hydrogel technology into an internationally recognized standard of care in advanced ENT (Ear, Nose, and Throat) surgery.

George Hermann, a Stanford trained mechanical engineer, has a 40+ year history in successful medical device product development and is most well-known for his long-term position leading up product innovation with prominent inventor/surgeon Dr. Thomas Fogarty. Together, they formed the nidus for numerous startup companies that included the development of products in cardiovascular surgery, cardiology, urology, general surgery, women’s healthcare and beyond.

Gil is a medical device executive and engineering leader with over 25 years of experience driving innovation across disposables, implants, and robotics. He specializes in leading R&D and manufacturing organizations through the full product lifecycle, from early-stage design through scaled commercial production, with a consistent track record of building world-class operations that transform start-ups into profitable, high-growth enterprises, several of which were later acquired by industry leaders including Medtronic, Hologic, and Baxter.In 2010, Gil joined Focal Therapeutics, where he played a key role in developing and scaling manufacturing for the BioZorb 3D Bioabsorbable Marker, guiding the product from early production through commercial scale and helping establish it as a widely adopted tool in breast cancer treatment planning. Throughout his career, Gil has combined deep technical expertise with strong operational leadership to deliver complex, regulated products at scale.

Taryn Irigoyen is a recent Fresno State graduate with a degree in Agricultural Business and a former Division I softball student-athlete. Through NIL opportunities during her collegiate career, she discovered a passion for social media marketing and learned to balance multiple responsibilities while creating engaging, impactful content. With a strong appreciation for teamwork, innovation, and community, she enjoys using creative storytelling to educate others, promote everyday wellness, and help innovative brands like NasoClenz connect with their audiences.

Andy is an executive mentor, career adviser and consultant with more than 35 years’ experience in banking and wealth management. He has extensive experience in global financial and capital markets, risk management, governance and executive leadership. With a career spanning London, New York, Sydney, Auckland and Queenstown his major roles include Head of Wealth at Westpac New Zealand, GM - Europe & America at Westpac, Treasurer at Lloyds Bank, Australia and CEO of NZAM.

A leading authority on consumer brand strategy and digital commerce, David Bell is Professor Emeritus at the Wharton School and a Stanford-trained economist. As an early backer of Warby Parker, Harry’s, Bonobos, and Jet, he translated DTC success into foundational principles that founders still build on today. His rigorous, data-driven lens shapes how new consumer categories are defined and captured.

Executive R&D and Business Development professional with a range of start-up to public company experience in the MedTech industry. Skilled in Medical Devices, Management, Capital Equipment, U.S. Food and Drug Administration (FDA), international regulatory, compliance, and clinical affairs, and Research and Development (R&D) functional oversight. He is typically the lead executive responsible for identifying targets, conducting due diligence, and, most importantly, managing the post-merger integration of technology and R&D teams.